Ikarian Capital’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Ikarian Capital's ANRO Position: Q3 2026 in Review
Ikarian Capital increased its Alto Neuroscience (ANRO) stake by 18% in Q3 2026, buying an estimated $2.25M and bringing the position to 482,338 shares worth $12.3M. The position accounts for 1.24% of the portfolio, ranked #20.
Ikarian Capital first reported a position in ANRO in Q4 2024 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Ikarian Capital held 482,338 shares of Alto Neuroscience worth $12.3M as of Q3 2026.
- Ikarian Capital bought 75,000 Alto Neuroscience shares in Q3 2026, an estimated $2.25M.
- Alto Neuroscience made up 1.24% of Ikarian Capital's portfolio in Q3 2026, its #20 holding.
- Ikarian Capital first reported a position in Alto Neuroscience in Q4 2024 and has held it in 8 quarters since.
- 126 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Ikarian Capital's 13F filing for Q3 2026, filed 16 Nov 2026.